Diaminopropanol tetraacetic acid
- Generic Name
- Diaminopropanol tetraacetic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C11H18N2O9
- CAS Number
- 3148-72-9
- Unique Ingredient Identifier
- 949B9ZMO7M
- Background
Diaminohydroxypropanetetraacetic acid has been investigated for the treatment of Vascular Disease, Coronary Disease, Myocardial Ischemia, Coronary Restenosis, and Coronary Artery Disease, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
Phase 3
Completed
- Conditions
- Myocardial Infarction, AcuteLeft Ventricular Thrombus
- Interventions
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 560
- Registration Number
- NCT05077683
- Locations
- 🇫🇷
HEGP, Paris, France
Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure
Phase 2
Completed
- Conditions
- Atrial FibrillationAtrial AppendageHemorrhage
- Interventions
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2021-12-21
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 105
- Registration Number
- NCT03273322
- Locations
- 🇫🇷
Institut de Cardiologie - Hôpital Pitié-Salpêtrière, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath